top of page

Evaluation of the Initial Prescription of Ketamine and Milnacipran for Depression in Palliative Care

About the study

NCT Trial Number

NCT02783430

The drug being studied

Ketamine

noun_Drug_2240951.png
noun_Institution_118530.png

Sponsored by

University Hospital, Lille

noun_date_3237048.png

Trial Start Date

Sep-16

noun_capsule_138144.png

About the participants

Age seeking

18 Years and older

gender

All

noun_Mental Health_2683241.png

Primary condition of volunteers accepted

Depression

noun_square_138133.png

Accepts healthy volunteers?

No

This study evaluates a new therapeutic strategy that could integrate ketamine in the same time than SSRI, to control depression symptoms faster and optimize patient's quality of life complementary to treatments of cancer.

Eyes Graffiti

Locations

France
University Hospital, Not yet recruiting
Lille, France

Contact: Magali Pierrat, MD

Centre Hospitalier de Valenciennes
Valenciennes, France

​

​

​

​

Get in contact

Find a study site convenient for you below, then email yourself the contact details and next steps

bottom of page